Literature DB >> 26321590

Bipolar disorder: Functional neuroimaging markers in relatives.

Camille Piguet1, Leon Fodoulian2, Jean-Michel Aubry3, Patrik Vuilleumier4, Josselin Houenou5.   

Abstract

Neural models of anatomical and functional alterations have been proposed for bipolar disorders (BD). However, studies in affected patients do not allow disentangling alterations linked to the liability to BD from those associated with the evolution, medication and comorbidities of BD. Explorations in high risk subjects allow the study of these risk markers. We reported and summarized all functional magnetic resonance imaging (fMRI) studies focusing on first-degree relatives of BD patients. We found 29 studies reporting neural correlates of working memory (WM), emotional processing, executive functions and resting state in relatives of BD patients, compared to healthy subjects. Overall, the same regions that have been involved in patients, such as the inferior frontal gyrus and limbic areas, seem to be functionally altered in high-risk subjects. We conclude that the same brain regions already implicated in the pathophysiology of the disease such as the amygdala are also associated with the risk of BD. However longitudinal studies are required to understand their implication in the transition to BD.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; High-risk; Relatives; Vulnerability; fMRI

Mesh:

Year:  2015        PMID: 26321590     DOI: 10.1016/j.neubiorev.2015.08.015

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  7 in total

1.  Neuroimaging correlates of emotional response-inhibition discriminate between young depressed adults with and without sub-threshold bipolar symptoms (Emotional Response-inhibition in Young Depressed Adults).

Authors:  Jungwon Cha; Sidra Speaker; Bo Hu; Murat Altinay; Parashar Koirala; Harish Karne; Jeffrey Spielberg; Amy Kuceyeski; Elvisha Dhamala; Amit Anand
Journal:  J Affect Disord       Date:  2020-12-10       Impact factor: 4.839

Review 2.  Neurobiology of Risk for Bipolar Disorder.

Authors:  Ayşegül Özerdem; Deniz Ceylan; Güneş Can
Journal:  Curr Treat Options Psychiatry       Date:  2016-10-20

Review 3.  Alterations of Intrinsic Brain Connectivity Patterns in Depression and Bipolar Disorders: A Critical Assessment of Magnetoencephalography-Based Evidence.

Authors:  Golnoush Alamian; Ana-Sofía Hincapié; Etienne Combrisson; Thomas Thiery; Véronique Martel; Dmitrii Althukov; Karim Jerbi
Journal:  Front Psychiatry       Date:  2017-03-17       Impact factor: 4.157

4.  Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.

Authors:  Jeff Zarp Petersen; Lejla Sjanic Schmidt; Maj Vinberg; Martin Balslev Jørgensen; Ida Hageman; Hannelore Ehrenreich; Gitte Moos Knudsen; Lars Vedel Kessing; Kamilla Woznica Miskowiak
Journal:  Trials       Date:  2018-11-06       Impact factor: 2.279

5.  Altered Electroencephalographic Resting-State Large-Scale Brain Network Dynamics in Euthymic Bipolar Disorder Patients.

Authors:  Alena Damborská; Camille Piguet; Jean-Michel Aubry; Alexandre G Dayer; Christoph M Michel; Cristina Berchio
Journal:  Front Psychiatry       Date:  2019-11-15       Impact factor: 4.157

6.  Aberrant structural covariance networks in youth at high familial risk for mood disorder.

Authors:  Kareen Heinze; Xueyi Shen; Emma Hawkins; Mathew A Harris; Laura de Nooij; Andrew M McIntosh; Stephen J Wood; Heather C Whalley
Journal:  Bipolar Disord       Date:  2019-11-23       Impact factor: 6.744

7.  Shared and differential cortical functional abnormalities associated with inhibitory control in patients with schizophrenia and bipolar disorder.

Authors:  Noa Tsujii; Wakako Mikawa; Toru Adachi; Tomoyuki Hirose; Osamu Shirakawa
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.